Zynex reports third quarter 2023 financial results

Q3 2023 revenue increased 20% to $49.9 million; eps $0.10 englewood, colo. , oct. 26, 2023 /prnewswire/ -- zynex, inc. (nasdaq: zyxi), an innovative medical technology company specializing in the manufacture and sale of non-invasive medical devices for pain management, rehabilitation, and patient monitoring, has reported its financial and operational results for the third quarter ended september 30, 2023.
ZYXI Ratings Summary
ZYXI Quant Ranking